A t-PA/nanoparticle conjugate with fully retained enzymatic activity and prolonged circulation time
{{output}}
A major issue in the therapeutic use of tissue plasminogen activator (t-PA) for the treatment of thrombotic diseases is its very short half-life in the circulation due to the effects of inhibitors. The present study aims to resolve the issue using a t-PA/gold ... ...
